Radiation 'Warhead' trial aims to give tough leukemia patients a fighting chance
Disease control
Not yet recruiting
This study is testing a new treatment approach for adults with acute myeloid leukemia (AML) that has returned or not responded to standard therapies. It combines a targeted radiation drug with chemotherapy and low-dose whole-body radiation to prepare patients for a stem cell tran…
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC